Toronto stock exchange: the trading of shares of companies of cannabis briefly interrupted

Photo: Darren Calabrese The canadian Press
During the five previous sessions from December 20 to December 27, Aphria had won 24.4 percent, Aurora 27,2 %, Canopy Growth 29.8% and MedReleaf, is 26.4 %.

A number of canadian companies in the sector of cannabis were seen trading in their shares on the Toronto stock Exchange be temporarily suspended early Friday afternoon, due to sudden shifts in value.

 

The canadian regulator of the securities trade (IIROC) has suspended trading on Canopy Growth, Aphria, Aurora Cannabis and MedReleaf between approximately 12: 15 a.m. and 12: 30. Activities have resumed for all the actions in the space of about ten minutes.

 

Shortly before the interruption, the action of Canopy Growth had fallen to 14.8 %, that of Aphria 15.5 %, while the title of Aurora slipped 14.7% and that of MedReleaf, 19.2 %.

 

IIROC has indicated that the interruption had been made under the rule of the circuit-breaker by title, which restricts the fluctuations of the prices of major canadian titles. This means an interruption of safety of five minutes automatically triggered — which may be extended to five minutes, on all canadian equity markets if the price of a share varies by 10% or more in a five minute period.

 

Vahan Ajamian, an analyst at Beacon Securities, said that the setbacks sudden in the stock prices of companies in the sector cannabis could be explained by the desire of investors to reap gains at the end of the year.

 

The canadian equity sector of the marijuana have pushed the health care sector of the Toronto stock Exchange this week, playing also an important role in the high levels achieved by the composite index TSX/S P Wednesday and Thursday. During the five previous sessions from December 20 to December 27, Aphria had won 24.4 percent, Aurora 27,2 %, Canopy Growth 29.8% and MedReleaf, is 26.4 %.

 

Canadian companies in the sector of marijuana were flying high during the most recent quarter by increasing production capacity in view of the realization of the legalization of cannabis the next summer, while expanding their activities outside the country’s borders. In the last month, the action of Aphria has jumped by 56 %, from of 11.47 $ on November 28, to $ 18 on December 28. During the same period, Aurora has seen its title to climb 14 %, of 7.83 to $ 8,94 $. The action of Canopy Growth has advanced to 61 %, of 18.85 to $ 30,41 $, while that of MedReleaf has gained 24 %, to $ 16.19 per to 20,19 $.

 

They have, for the most part, erased their loss in the session, even closed up. The action of Aphria has finished 18.70 to $, an increase of 4 % compared to the previous day, that of Aurora at $ 9.60 per, an increase of 7 %, while the titles of Canopy Growth and MedReleaf were respectively 29,74 $ (- 2 % on the session) and at 21.05 $ (+5 %).

Share Button